Siemens Acuson 13L4 Ultrasound Probe Linear Transducer for Juniper

Name: Siemens Acuson 13L4 Ultrasound Probe Linear Transducer for Juniper
Brand: Shenzhen Reyardmed Technology Limited.
SKU: 2087928402

Guangdong, ChinaShenzhen Reyardmed Technology Limited.

US$1,000.00-5,000.00

1 Piece

Product profile

Customization

Available

Customized

Certification

CE, FDA, ISO13485

Model NO.

13L4

Scale

Medium

Brand

Siemens Acuson

Model

13L4

Type

Linear

Frequency

7.5MHz

Compatible Systems

Juniper

Applications

Ob/Gyn, Msk, Gi

Materials

Metal, Plastics

Warranty

Six Months

Transport Package

Common Box

Origin

China

HS Code

9018129190

Production Capacity

50000PCS/Year

Key features

CE Certification: Product meets CE safety and quality standards for medical devices.

Linear Transducer Type: Designed for Ob/Gyn, MSK, and GI applications with 7.5MHz frequency.

Customized Options: Customization available for specific clinical requirements.

Compatible with Juniper: Fully compatible with Juniper ultrasound imaging systems.

Durable Materials: Constructed with high-quality metal and plastics for longevity.

Global Standards Compliance: Meets CE, FDA, and international quality manufacturing standards.

ISO-Certified Repair: Backed by ISO-certified repair center with 100% quality guarantee.

Comprehensive Support: Provides pre-sales consultation and after-sales technical assistance.

Company profile

Shenzhen Reyardmed Technology Limited.

Guangdong, China

Business Type: Trading CompanyAverage Response Time: ≤2.08h

AI-Powered supplier vetting

SummaryThe supplier is a limited trading company offering ultrasound probes and related medical-device, technology, rental, consulting, and trading services. It reports ISO 13485 certification, 11–20 years of combined R&D-engineer experience, 6–10 quality-control staff, broad export coverage, and order fulfillment within 15 working days in both peak and off-peak periods. However, it does not provide OEM services for popular brands or an SDK, and the available quality-control evidence identifies zero quality-control test equipment, no written corrective/preventive-action or complaint-handling procedures, and unknown quality-assurance and traceability status. Financial records are referenced for 2022–2024, but no usable financial performance figures are provided. Customer relationships across multiple regions are described, but no specific customer cases are named.

CertificationsThe supplier reports holding ISO 13485 certification, a medical-device quality-management certification. The slices do not provide the certificate number, validity period, certification scope, or product coverage, so the certification is evidenced but its applicability cannot be fully assessed.

After-Sales capabilityThe supplier describes support from pre-sales consultation through after-sales technical assistance and states that it serves hospitals, clinics, and distributors internationally. However, it also reports no written procedures or records for corrective and preventive actions or customer-complaint handling, which shows a documented service-process deficiency despite the stated support commitment.

Production capacityThe supplier offers ultrasound probes, reports an annual production-output range, exports to multiple regions, and states order fulfillment within 15 working days in both peak and off-peak seasons. Against these positive operational indicators, the quality-control slice reports zero quality-control test equipment and unknown quality-assurance and traceability status, creating a clear documented weakness in production-quality infrastructure.

Customization capabilityThe supplier lists technology development, consultation, exchange, transfer, and technical services, and has reported R&D-engineer experience. However, it explicitly does not provide OEM services for popular brands and has no available SDK; no other product-customization process or capabilities are documented.